Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome

Stopped Lack of funding, never moved into the phase II portion that was originally planned.

Conditions

• Myelodysplastic Syndromes

Interventions

• DRUG: sodium stibogluconate

Sponsor

Northwestern University

Collaborators

• [object Object]